On the other hand, an anti-metastatic activity of the axis CCL2-CCR2 has also been reported, as CCL2 expression levels in prostate cancer correlate with the degree of tumor aggressiveness [44], and absence of CCL2 in cervical cancer has been associated with relapse-free survival [45]. The gene discussed is CCL2; the disease is prostate carcinoma.